This publication summarises a Novartis-sponsored breakfast symposium presentation given by Dr Adam Nelson of the University of Adelaide and chaired by Professor Ralph Stewart at the recent 2024 CSANZ New Zealand Annual Scientific Meeting, held in Christchurch.
Please login below to download this issue (PDF)